Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies
Public ClinicalTrials.gov record NCT00688519. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Phase 3 Study of the Safety and Efficacy of Emulsion Formulation U0267, Versus Vehicle in Subjects With Plaque-type Psoriasis
Study identification
- NCT ID
- NCT00688519
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Stiefel, a GSK Company
- Industry
- Enrollment
- 336 participants
Conditions and interventions
Conditions
Interventions
- U0267 Drug
- Vehicle Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 29, 2008
- Primary completion
- Nov 30, 2008
- Completion
- Nov 30, 2008
- Last update posted
- Jan 1, 2017
2008
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Therapeutics Clinical Research Center, Inc. | San Diego | California | 92123 | — |
| Cherry Creek Research, Inc. | Denver | Colorado | 80209 | — |
| Florida Academic Dermatology Centers | Miami | Florida | 33136 | — |
| FXM Research | Miami | Florida | 33175 | — |
| DermResearch, PLLC | Louisville | Kentucky | 40217 | — |
| Massachusetts General Hospital Clinical Unit for Research Trials in Skin | Boston | Massachusetts | 02114 | — |
| Minnesota Clinical Study Center | Fridley | Minnesota | 55432 | — |
| Mount Sinai School of Medicine, Department of Dermatology | New York | New York | 10029 | — |
| Dermatology Consulting Services | High Point | North Carolina | 27262 | — |
| Oregon Medical Research Center, P.C. | Portland | Oregon | 97223 | — |
| Dermatology Treatment & Research Center | Dallas | Texas | 75230 | — |
| The Center for Skin Research | Houston | Texas | 77056 | — |
| Dermatology Research Center, Inc. | Salt Lake City | Utah | 84124 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00688519, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 1, 2017 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00688519 live on ClinicalTrials.gov.